Results 181 to 190 of about 6,860 (236)
Some of the next articles are maybe not open access.
THE ULUTAS MEDICAL JOURNAL, 2022
This meta-analysis investigated whether the clinical efficacy of doripenem is comparable to that of alternative antibiotics for treating hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP).
Kun-Ji Wu, C. Chao, Guang-Mao Lee
semanticscholar +1 more source
This meta-analysis investigated whether the clinical efficacy of doripenem is comparable to that of alternative antibiotics for treating hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP).
Kun-Ji Wu, C. Chao, Guang-Mao Lee
semanticscholar +1 more source
Evaluating the efficacy of doripenem against Staphylococcus aureus in vancomycin-resistant strains
Microbial PathogenesisDetermination of antibiotic susceptibility is a crucial aspect of antimicrobial therapy. The objective of this study was to determine the specific susceptibility of Staphylococcus aureus (SA) to the antibiotic doripenem.
Pitchiah Sivaperumal +2 more
exaly +2 more sources
Journal of chemotherapy, 2020
This study aims to analyze the effect of ceftazidime/avibactam plus various antibiotics against OXA-48-producing Enterobacterales isolated from Intensive Care Units.
Emel Mataracı Kara +3 more
semanticscholar +1 more source
This study aims to analyze the effect of ceftazidime/avibactam plus various antibiotics against OXA-48-producing Enterobacterales isolated from Intensive Care Units.
Emel Mataracı Kara +3 more
semanticscholar +1 more source
The in vitro activity of doripenem against prevalent nonfermentative Gram-negative bacilli and Aeromonas spp. was evaluated. The collection comprised 14979 nonduplicate clinical isolates submitted during a global Doripenem Surveillance Program conducted ...
Mariana Castanheira +2 more
exaly +2 more sources
Doripenem: antimicrobial profile and clinical potential
Diagnostic Microbiology and Infectious Disease, 2009David M Livermore
exaly +4 more sources
Journal of Applied Pharmaceutical Sciences
Doripenem (DM), an antibiotic used for kidney, lung, and urinary infections, underwent the development of a robust high-performance liquid chromatography (HPLC) technique using the quality-by-design approach.
N. V. V. D. P. Boppy +7 more
semanticscholar +1 more source
Doripenem (DM), an antibiotic used for kidney, lung, and urinary infections, underwent the development of a robust high-performance liquid chromatography (HPLC) technique using the quality-by-design approach.
N. V. V. D. P. Boppy +7 more
semanticscholar +1 more source
Hospital Pharmacy, 2008
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to your Pharmacy & Therapeutics Committee. Subscribers also receive monthly 1-page summary monographs on the agents that are useful for agendas and pharmacy ...
Dennis J. Cada +3 more
openaire +1 more source
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to your Pharmacy & Therapeutics Committee. Subscribers also receive monthly 1-page summary monographs on the agents that are useful for agendas and pharmacy ...
Dennis J. Cada +3 more
openaire +1 more source
Microchemical journal (Print), 2019
Doripenem monohydrate (DOR), is a recently FDA approved β- lactam antibiotic. DOR belongs to carbapenems class and it is used for the treatment of several diseases caused by different strains of bacteria.
Baher I. Salman +3 more
semanticscholar +1 more source
Doripenem monohydrate (DOR), is a recently FDA approved β- lactam antibiotic. DOR belongs to carbapenems class and it is used for the treatment of several diseases caused by different strains of bacteria.
Baher I. Salman +3 more
semanticscholar +1 more source
Doripenem: A new carbapenem antibiotic
American Journal of Health-System Pharmacy, 2010The chemistry, pharmacology, antimicrobial activity, pharmacokinetics, pharmacodynamics, efficacy and safety in humans, and formulary considerations of doripenem are reviewed.Doripenem, a member of the β-lactam class of antibiotics, is the newest addition to the carbapenems.
Elias B, Chahine +2 more
openaire +2 more sources

